36.35
price up icon4.97%   1.72
pre-market  Pre-mercato:  36.75   0.40   +1.10%
loading
Precedente Chiudi:
$34.63
Aprire:
$34.86
Volume 24 ore:
1.30M
Relative Volume:
1.03
Capitalizzazione di mercato:
$2.70B
Reddito:
-
Utile/perdita netta:
$-275.16M
Rapporto P/E:
-9.3445
EPS:
-3.89
Flusso di cassa netto:
$-221.15M
1 W Prestazione:
+11.85%
1M Prestazione:
+2.14%
6M Prestazione:
-3.63%
1 anno Prestazione:
-8.76%
Intervallo 1D:
Value
$34.63
$37.59
Intervallo di 1 settimana:
Value
$31.95
$37.59
Portata 52W:
Value
$28.21
$53.92

Springworks Therapeutics Inc Stock (SWTX) Company Profile

Name
Nome
Springworks Therapeutics Inc
Name
Telefono
203-883-9490
Name
Indirizzo
100 WASHINGTON BOULEVARD, STAMFORD, CT
Name
Dipendente
305
Name
Cinguettio
@springworkstx
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
SWTX's Discussions on Twitter

Confronta SWTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SWTX
Springworks Therapeutics Inc
36.35 2.70B 0 -275.16M -221.15M -3.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-20 Iniziato Evercore ISI Outperform
2024-02-05 Iniziato Guggenheim Buy
2022-12-01 Iniziato BofA Securities Buy
2021-01-19 Reiterato H.C. Wainwright Buy
2020-10-29 Reiterato H.C. Wainwright Buy
2020-05-05 Iniziato Barclays Overweight
2020-03-19 Aggiornamento H.C. Wainwright Neutral → Buy
2020-03-04 Downgrade H.C. Wainwright Buy → Neutral
2020-01-21 Reiterato H.C. Wainwright Buy
2019-12-04 Iniziato H.C. Wainwright Buy
2019-10-08 Iniziato Cowen Outperform
2019-10-08 Iniziato Goldman Buy
2019-10-08 Iniziato JP Morgan Overweight
2019-10-08 Iniziato Wedbush Outperform
Mostra tutto

Springworks Therapeutics Inc Borsa (SWTX) Ultime notizie

pulisher
Jan 21, 2025

AMI Asset Management Corp Invests $1.44 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Jan 21, 2025
pulisher
Jan 20, 2025

Analysts Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Target Price at $70.00 - MarketBeat

Jan 20, 2025
pulisher
Jan 18, 2025

SWTX Announces 2024 Preliminary Results, 2025 Goals, Stock Down - MSN

Jan 18, 2025
pulisher
Jan 17, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Trading Down 6.4%Time to Sell? - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Trading Up 4.3%Time to Buy? - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Equities Analysts Set Expectations for SWTX FY2024 Earnings - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

SpringWorks Therapeutics' SWOT analysis: biotech stock shows promise amid challenges - MSN

Jan 16, 2025
pulisher
Jan 16, 2025

Research Analysts Set Expectations for SWTX FY2024 Earnings - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Equities Analysts Offer Predictions for SWTX FY2027 Earnings - Defense World

Jan 16, 2025
pulisher
Jan 15, 2025

SpringWorks Therapeutics Stock Sees RS Rating Jump To 86 - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap DownHere's What Happened - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

Wedbush Research Analysts Reduce Earnings Estimates for SWTX - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

JPMorgan Chase & Co. Lowers Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Strength Seen in SpringWorks Therapeutics (SWTX): Can Its 6.0% Jump Turn into More Strength? - MSN

Jan 14, 2025
pulisher
Jan 14, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 6.4%Time to Sell? - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Items Tagged with 'RPT-04402' - BioWorld Online

Jan 14, 2025
pulisher
Jan 14, 2025

Items Tagged with 'SW-3431' - BioWorld Online

Jan 14, 2025
pulisher
Jan 14, 2025

Springworks licenses molecular glue targeting PP2A from Rappta - BioWorld Online

Jan 14, 2025
pulisher
Jan 14, 2025

Why Springworks Therapeutics Stock is Tumbling - TipRanks

Jan 14, 2025
pulisher
Jan 14, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Given Outperform Rating at Wedbush - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

Wedbush Reiterates "Outperform" Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps. - MSN

Jan 13, 2025
pulisher
Jan 13, 2025

SpringWorks to Develop Rappta’s First-in-Class Cancer Drug - Contract Pharma

Jan 13, 2025
pulisher
Jan 13, 2025

SpringWorks Therapeutics Stock Gets A RS Rating Lift - MSN

Jan 13, 2025
pulisher
Jan 13, 2025

SpringWorks Therapeutics Reports Strong 2024 Financial Results - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

SpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

SpringWorks Therapeutics Reports Preliminary Fourth Quarter - GlobeNewswire

Jan 13, 2025
pulisher
Jan 13, 2025

SpringWorks Therapeutics Hits $172M Revenue in 2024 as OGSIVEO Launch Accelerates Growth - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

SpringWorks: PDUFA Review Date Could Lead To Next Approved Pipeline Candidate (SWTX) - Seeking Alpha

Jan 13, 2025
pulisher
Jan 11, 2025

SpringWorks Therapeutics jumps amid takeover speculation - MSN

Jan 11, 2025
pulisher
Jan 10, 2025

Guggenheim Lowers SpringWorks Therapeutics (NASDAQ:SWTX) Price Target to $78.00 - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim - Yahoo Finance

Jan 09, 2025
pulisher
Jan 08, 2025

Guggenheim Cuts SpringWorks Therapeutics (NASDAQ:SWTX) Price Target to $78.00 - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

SpringWorks Therapeutics Trying To Close In On Key Technical Measure - MSN

Jan 08, 2025
pulisher
Jan 08, 2025

Guggenheim maintains Buy rating on SpringWorks stock despite minor target adjustment - Investing.com UK

Jan 08, 2025
pulisher
Jan 08, 2025

SpringWorks Therapeutics price target lowered to $55 from $58 at BofA - Yahoo Finance

Jan 08, 2025
pulisher
Jan 07, 2025

Chief People Officer Pichl Daniel covered exercise/tax liability with 7,269 shares, decreasing direct ownership by 16% to 37,943 units (SEC Form 4) - Quantisnow

Jan 07, 2025
pulisher
Jan 07, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Trading 6.8% HigherTime to Buy? - MarketBeat

Jan 07, 2025
pulisher
Jan 06, 2025

Desmoid Tumors Market to Reach New Heights in Growth by 2034, - openPR

Jan 06, 2025
pulisher
Jan 03, 2025

SpringWorks Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 03, 2025
pulisher
Jan 03, 2025

SpringWorks Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Jan 03, 2025
pulisher
Dec 31, 2024

SpringWorks: With Catalyst On The Horizon And Growing Sales, 2025 Looks Great - Seeking Alpha

Dec 31, 2024
pulisher
Dec 29, 2024

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $69.50 Consensus Target Price from Brokerages - Defense World

Dec 29, 2024
pulisher
Dec 27, 2024

How To Trade (SWTX) - Stock Traders Daily

Dec 27, 2024
pulisher
Dec 27, 2024

Ethanol Futures (ZKZ25) Quote - The Globe and Mail

Dec 27, 2024

Springworks Therapeutics Inc Azioni (SWTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):